191 related articles for article (PubMed ID: 17635665)
1. Lifeguard/neuronal membrane protein 35 regulates Fas ligand-mediated apoptosis in neurons via microdomain recruitment.
Fernández M; Segura MF; Solé C; Colino A; Comella JX; Ceña V
J Neurochem; 2007 Oct; 103(1):190-203. PubMed ID: 17635665
[TBL] [Abstract][Full Text] [Related]
2. Cholangiocarcinomas express Fas ligand and disable the Fas receptor.
Que FG; Phan VA; Phan VH; Celli A; Batts K; LaRusso NF; Gores GJ
Hepatology; 1999 Dec; 30(6):1398-404. PubMed ID: 10573518
[TBL] [Abstract][Full Text] [Related]
3. Amplification of Fas-mediated apoptosis in type II cells via microdomain recruitment.
Legembre P; Daburon S; Moreau P; Ichas F; de Giorgi F; Moreau JF; Taupin JL
Mol Cell Biol; 2005 Aug; 25(15):6811-20. PubMed ID: 16024813
[TBL] [Abstract][Full Text] [Related]
4. Expression level of c-FLIP versus Fas determines susceptibility to Fas ligand-induced cell death in murine thymoma EL-4 cells.
Kataoka T; Ito M; Budd RC; Tschopp J; Nagai K
Exp Cell Res; 2002 Feb; 273(2):256-64. PubMed ID: 11822881
[TBL] [Abstract][Full Text] [Related]
5. The TRAF3-binding site of human molluscipox virus FLIP molecule MC159 is critical for its capacity to inhibit Fas-induced apoptosis.
Thurau M; Everett H; Tapernoux M; Tschopp J; Thome M
Cell Death Differ; 2006 Sep; 13(9):1577-85. PubMed ID: 16410799
[TBL] [Abstract][Full Text] [Related]
6. FasL (CD95L/APO-1L) resistance of neurons mediated by phosphatidylinositol 3-kinase-Akt/protein kinase B-dependent expression of lifeguard/neuronal membrane protein 35.
Beier CP; Wischhusen J; Gleichmann M; Gerhardt E; Pekanovic A; Krueger A; Taylor V; Suter U; Krammer PH; Endres M; Weller M; Schulz JB
J Neurosci; 2005 Jul; 25(29):6765-74. PubMed ID: 16033886
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of Fas-mediated apoptosis by an engineered glycosylphosphatidylinositol-linked Fas.
Legembre P; Moreau P; Daburon S; Moreau JF; Taupin JL
Cell Death Differ; 2002 Mar; 9(3):329-39. PubMed ID: 11859415
[TBL] [Abstract][Full Text] [Related]
8. The extracellular domains of FasL and Fas are sufficient for the formation of supramolecular FasL-Fas clusters of high stability.
Henkler F; Behrle E; Dennehy KM; Wicovsky A; Peters N; Warnke C; Pfizenmaier K; Wajant H
J Cell Biol; 2005 Mar; 168(7):1087-98. PubMed ID: 15795317
[TBL] [Abstract][Full Text] [Related]
9. Ligand-independent redistribution of Fas (CD95) into lipid rafts mediates clonotypic T cell death.
Muppidi JR; Siegel RM
Nat Immunol; 2004 Feb; 5(2):182-9. PubMed ID: 14745445
[TBL] [Abstract][Full Text] [Related]
10. c-FLIP expression in bladder urothelial carcinomas: its role in resistance to Fas-mediated apoptosis and clinicopathologic correlations.
Korkolopoulou P; Goudopoulou A; Voutsinas G; Thomas-Tsagli E; Kapralos P; Patsouris E; Saetta AA
Urology; 2004 Jun; 63(6):1198-204. PubMed ID: 15183989
[TBL] [Abstract][Full Text] [Related]
11. Fas ligand-induced apoptosis is regulated by nitric oxide through the inhibition of fas receptor clustering and the nitrosylation of protein kinase Cepsilon.
Dash PR; McCormick J; Thomson MJ; Johnstone AP; Cartwright JE; Whitley GS
Exp Cell Res; 2007 Oct; 313(16):3421-31. PubMed ID: 17761163
[TBL] [Abstract][Full Text] [Related]
12. Fas signaling induces raft coalescence that is blocked by cholesterol depletion in human RPE cells undergoing apoptosis.
Lincoln JE; Boling M; Parikh AN; Yeh Y; Gilchrist DG; Morse LS
Invest Ophthalmol Vis Sci; 2006 May; 47(5):2172-8. PubMed ID: 16639029
[TBL] [Abstract][Full Text] [Related]
13. Fas transduces dual apoptotic and trophic signals in hematopoietic progenitors.
Pearl-Yafe M; Stein J; Yolcu ES; Farkas DL; Shirwan H; Yaniv I; Askenasy N
Stem Cells; 2007 Dec; 25(12):3194-203. PubMed ID: 17872500
[TBL] [Abstract][Full Text] [Related]
14. FAP-1-mediated activation of NF-kappaB induces resistance of head and neck cancer to Fas-induced apoptosis.
Wieckowski E; Atarashi Y; Stanson J; Sato TA; Whiteside TL
J Cell Biochem; 2007 Jan; 100(1):16-28. PubMed ID: 16888780
[TBL] [Abstract][Full Text] [Related]
15. Fas/CD95 death receptor and lipid rafts: new targets for apoptosis-directed cancer therapy.
Mollinedo F; Gajate C
Drug Resist Updat; 2006; 9(1-2):51-73. PubMed ID: 16687251
[TBL] [Abstract][Full Text] [Related]
16. c-FLIP expression in colorectal carcinomas: association with Fas/FasL expression and prognostic implications.
Korkolopoulou P; Saetta AA; Levidou G; Gigelou F; Lazaris A; Thymara I; Scliri M; Bousboukea K; Michalopoulos NV; Apostolikas N; Konstantinidou A; Tzivras M; Patsouris E
Histopathology; 2007 Aug; 51(2):150-6. PubMed ID: 17559541
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of apoptosis by expression of antiapoptotic proteins in recombinant human keratinocytes.
Choi CY; Reimers K; Allmeling C; Kall S; Choi YH; Vogt PM
Cell Transplant; 2007; 16(6):663-74. PubMed ID: 17912957
[TBL] [Abstract][Full Text] [Related]
18. Expression of Fas and Fas-ligand in donor hematopoietic stem and progenitor cells is dissociated from the sensitivity to apoptosis.
Pearl-Yafe M; Yolcu ES; Stein J; Kaplan O; Shirwan H; Yaniv I; Askenasy N
Exp Hematol; 2007 Oct; 35(10):1601-12. PubMed ID: 17889725
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase C zeta associates with death inducing signaling complex and regulates Fas ligand-induced apoptosis.
Leroy I; de Thonel A; Laurent G; Quillet-Mary A
Cell Signal; 2005 Sep; 17(9):1149-57. PubMed ID: 15993755
[TBL] [Abstract][Full Text] [Related]
20. Role of membrane sphingomyelin and ceramide in platform formation for Fas-mediated apoptosis.
Miyaji M; Jin ZX; Yamaoka S; Amakawa R; Fukuhara S; Sato SB; Kobayashi T; Domae N; Mimori T; Bloom ET; Okazaki T; Umehara H
J Exp Med; 2005 Jul; 202(2):249-59. PubMed ID: 16009715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
